{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:58:48Z","timestamp":1761155928936},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.autrev.2015.03.005","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T06:58:30Z","timestamp":1428303510000},"page":"659-664","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature"],"prefix":"10.1016","volume":"14","author":[{"given":"Giacomo Maria","family":"Guidelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Tenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola Antonio","family":"Pascarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Galeazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2015.03.005_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.59.3.161","article-title":"Systemic vasculitis: epidemiology, classification and environmental factors","volume":"59","author":"Scott","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.03.005_bb0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.30286","article-title":"Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis","volume":"63","author":"Falk","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.005_bb0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s11926-005-0036-5","article-title":"Epidemiology of systemic vasculitis","volume":"7","author":"Lane","year":"2005","journal-title":"Curr. Rheumatol Rep"},{"key":"10.1016\/j.autrev.2015.03.005_bb0020","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg\u2013Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.03.005_bb0025","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary","volume":"33","author":"Fries","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.005_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.005_bb0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-142-8-200505030-00011","article-title":"Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) study","volume":"142","author":"Merkel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2015.03.005_bb0040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.autrev.2014.08.017","article-title":"Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment","volume":"13","author":"Commarmond","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.005_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.autrev.2012.08.008","article-title":"Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis","volume":"12","author":"Radice","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.005_bb0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.03.005_bb0055","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.03.005_bb0060","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2015.03.005_bb0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/art.23147","article-title":"Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic antibodies","volume":"58","author":"Martinez","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.005_bb0070","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/rheumatology\/35.11.1150","article-title":"Intravenous immunoglobulin as sole therapy for systemic vasculitis","volume":"35","author":"Jayne","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/jaut.1993.1018","article-title":"ANCA anti-idiotype antibodies and the treatment of systemic vasculitis with intravenous immunoglobulin","volume":"6","author":"Jayne","year":"1993","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.03.005_bb0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.1995.tb02268.x","article-title":"Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin","volume":"101","author":"Richter","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0085","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/rheumatology\/kem146a","article-title":"BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis","volume":"46","author":"Lapraik","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.03.005_bb0090","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2015.03.005_bb0095","first-page":"2488","article-title":"Vasculitis Clinical Research Consortium; OMERACT 7 Special Interest Group. Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7","volume":"32","author":"Merkel","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2015.03.005_bb0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.autrev.2013.01.003","article-title":"The future of immunoglobulin therapy: an overview of the 2nd international workshop on natural antibodies in health and disease","volume":"12","author":"Miescher","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.03.005_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/cei.1996.104.s1.77","article-title":"New treatment strategies for systemic vasculitis: the role of intravenous immunoglobulin therapy","volume":"104","author":"Lockwood","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0115","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/rheumatology\/keq021","article-title":"The role of high-dose intravenous immunoglobulin in rheumatology","volume":"49","author":"Vaitla","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.03.005_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1358\/dot.1999.35.7.548264","article-title":"Immunomodulation of various autoimmune diseases by intravenous immunoglobulin","volume":"35","author":"Sherer","year":"1999","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.autrev.2015.03.005_bb0125","series-title":"What is New?","first-page":"1","article-title":"Intravenous immunoglobulin (IVIG) therapy in autoimmune disease-SLE, antiphospholipid syndrome, vasculitis","author":"Sherer","year":"1999"},{"key":"10.1016\/j.autrev.2015.03.005_bb0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s281-001-8170-y","article-title":"Immunomodulation of autoimmune diseases by high-dose intravenous immunoglobulins","volume":"23","author":"Rauova","year":"2001","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08916930500059633","article-title":"IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients","volume":"38","author":"Shoenfeld","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2015.03.005_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000024199","article-title":"Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin","volume":"119","author":"Levy","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0145","first-page":"CD007057","article-title":"Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis","volume":"1","author":"Fortin","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2015.03.005_bb0150","article-title":"Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis","author":"Croft","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2015.03.005_bb0155","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/2277-9175.98129","article-title":"Wegener's granulomatosis and mucoromycosis: a case study and review of literature","volume":"1","author":"Abtahi","year":"2012","journal-title":"Adv Biomed Res"},{"key":"10.1016\/j.autrev.2015.03.005_bb0160","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcjo.2011.12.007","article-title":"Intravenous immunoglobulin (IVIG) for orbital Wegener's granulomatosis","volume":"47","author":"Wiwatwongwana","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0165","first-page":"S86","article-title":"Wegener's granulomatosis occurring de novo during pregnancy","volume":"27","author":"Alfhaily","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/s10165-008-0020-9","article-title":"Successful treatment of new onset Wegener's granulomatosis with IVIG (intravenous immunoglobulin) during pregnancy: a case report","volume":"18","author":"Kim","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semarthrit.2007.07.004","article-title":"Arterial aneurysms in Wegener's granulomatosis: case report and literature review","volume":"37","author":"Arlet","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.005_bb0180","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ncprheum0269","article-title":"A case of destructive Wegener's granulomatosis complicated by cytomegalovirus infection","volume":"2","author":"Aries","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0185","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10067-005-0057-5","article-title":"Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey","volume":"25","author":"Ozbalkan","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0190","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10067-004-0932-5","article-title":"Pregnancy in Wegener's granulomatosis: successful treatment with intravenous immunoglobulin","volume":"23","author":"Bellisai","year":"2004","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0195","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.pediatrneurol.2004.10.008","article-title":"Fatal neurologic involvement in pediatric Wegener's granulomatosis","volume":"32","author":"Ulinski","year":"2005","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0200","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1016\/S0272-6386(04)00986-2","article-title":"Wegener's granulomatosis in pregnancy: a novel approach to management","volume":"44","author":"Masterson","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.autrev.2015.03.005_bb0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00296-003-0422-0","article-title":"Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases","volume":"25","author":"Kamali","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2015.03.005_bb0210","first-page":"1577","article-title":"Wegener's granulomatosis associated with common variable immunodeficiency","volume":"29","author":"Del\u00e8vaux","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0215","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2015.03.005_bb0220","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1345\/aph.18439","article-title":"Treatment of Wegener's granulomatosis with immune globulin: CNS involvement in an adolescent female","volume":"33","author":"Taylor","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.autrev.2015.03.005_bb0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ppul.1950200410","article-title":"A case of pediatric Wegener's granulomatosis with recurrent venous thromboses treated with intravenous immunoglobulin and laryngotracheoplasty","volume":"20","author":"Adlakha","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0230","first-page":"1157","article-title":"Wegener's granulomatosis in the elderly\u2014unusual presentations and misdiagnosis","volume":"21","author":"Chakravarty","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0235","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(94)92152-0","article-title":"Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?","volume":"343","author":"Finkel","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2015.03.005_bb0240","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/978-1-4757-9182-2_88","article-title":"Treatment of Wegener's granulomatosis with intravenous immunoglobulin","volume":"336","author":"Richter","year":"1993","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0245","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10067-003-0725-2","article-title":"Eosinophilia and hyperimmunoglobulinemia E as the presenting manifestations of Wegener's granulomatosis","volume":"22","author":"Kamali","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0250","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/41.11.1303","article-title":"Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis","volume":"41","author":"Lamprecht","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.03.005_bb0255","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF00947090","article-title":"Early experience with intravenous immunoglobulin treatment in Wegener's granulomatosis with ocular involvement","volume":"235","author":"Blum","year":"1997","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0260","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMra1009433","article-title":"Intravenous immune globulin in autoimmune and inflammatory diseases","volume":"367","author":"Gelfand","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2015.03.005_bb0265","first-page":"877","article-title":"Long-term treatment of antiphospholipid syndrome with intravenous immunoglobulin in addition to conventional therapy","volume":"31","author":"Tenti","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0270","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2249.1991.tb05631.x","article-title":"Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis","volume":"83","author":"Rossi","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0275","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1385\/CRIAI:29:3:165","article-title":"Intravenous immunoglobulin new indications and mechanisms of action","volume":"29","author":"Shoenfeld","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0280","first-page":"568","article-title":"The beneficial effects of intravenous immunoglobulin for antineutrophil cytoplasmic antibody-positive vasculitis","volume":"14","author":"Svetlicky","year":"2012","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2015.03.005_bb0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0290","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1586\/1744666X.3.5.773","article-title":"The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases","volume":"3","author":"Zandman-Goddard","year":"2007","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2015.03.005_bb0295","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.autrev.2008.04.012","article-title":"What is the contents of the magic draft IVIg?","volume":"7","author":"Seite","year":"2008","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:30:56Z","timestamp":1566520256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1568997215000671"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.03.005","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulomatosis with polyangiitis and intravenous immunoglobulins: A case series and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}